靶向代谢组学方法用于脓毒症诱导的ARDS及其亚表型
该研究回顾性分析了2011年3月至2018年2月前瞻性收集的脓毒症登记中54例ARDS患者样本和30例非ARDS对照,采用液相色谱-串联质谱和气相色谱-质谱进行靶向代谢组学检测。共检测到186种代谢物,其中102种可区分脓毒症诱导的ARDS患者与非ARDS对照,14种可区分脓毒症诱导的ARDS亚表型。偏最小二乘判别分析显示两组代谢模式明显不同,主要区分代谢物为溶血磷脂酰乙醇胺缩醛磷脂、PE缩醛磷脂和磷脂酰胆碱;直接与间接ARDS亚表型也在代谢上不同,差异在于溶血磷脂酰胆碱。甘油磷脂代谢和鞘脂代谢分别是脓毒症诱导的ARDS生物学和直接/间接ARDS中最显著的代谢通路。
要点
- 共检测到186种代谢物,其中102种可区分脓毒症诱导的ARDS患者与非ARDS对照,14种可区分脓毒症诱导的ARDS亚表型。
- 溶血磷脂酰乙醇胺缩醛磷脂、PE缩醛磷脂和磷脂酰胆碱是区分脓毒症诱导的ARDS与非ARDS对照的主要代谢物。
- 脓毒症诱导的直接与间接ARDS在代谢上不同,差异代谢物为溶血磷脂酰胆碱。
- 甘油磷脂代谢是脓毒症诱导的ARDS生物学中最显著的代谢通路,鞘脂代谢是直接/间接ARDS中最显著的代谢通路。
适用人群与场景
- 脓毒症登记中前瞻性收集的脓毒症诱导的ARDS患者54例,以及非ARDS对照30例,样本于2011年3月至2018年2月收集。
诊断标准与关键阈值
- 采用偏最小二乘判别分析区分脓毒症诱导的ARDS患者与非ARDS对照,以及直接与间接ARDS亚表型。
研究设计与关键结果
- 研究类型为回顾性分析脓毒症登记中前瞻性收集的样本,共54例脓毒症诱导的ARDS患者和30例非ARDS对照,队列分为直接和间接ARDS。
- 采用液相色谱-串联质谱和气相色谱-质谱靶向代谢组学检测五类分析物(能量代谢、游离脂肪酸、氨基酸、磷脂、鞘脂)的代谢物浓度。
- 共检测到186种代谢物,其中102种可区分脓毒症诱导的ARDS患者与非ARDS对照,14种可区分脓毒症诱导的ARDS亚表型。
- 偏最小二乘判别分析显示脓毒症诱导的ARDS患者与非ARDS对照代谢明显不同,主要区分代谢物为溶血磷脂酰乙醇胺缩醛磷脂、PE缩醛磷脂和磷脂酰胆碱。
- 脓毒症诱导的直接与间接ARDS是代谢上不同的亚组,差异在于溶血磷脂酰胆碱。
- 甘油磷脂代谢和鞘脂代谢分别是脓毒症诱导的ARDS生物学和直接/间接ARDS中涉及的最显著代谢通路。
证据类型、等级与局限
- 证据类型:回顾性分析靶向代谢组学研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,所鉴定的代谢物和通路可为ARDS个体的诊断和治疗提供线索。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute respiratory distress syndrome (ARDS) is etiologically and clinically a heterogeneous disease. Its diagnostic characteristics and subtype classification, and the application of these features to treatment, have been of considerable interest. Metabolomics is becoming important for identifying ARDS biology and distinguishing its subtypes. This study aimed to identify metabolites that could distinguish sepsis-induced ARDS patients from non-ARDS controls, using a targeted metabolomics approach, and to identify whether sepsis-induced direct and sepsis-induced indirect ARDS are metabolically distinct groups, and if so, confirm their metabolites and associated pathways.
METHODS: This study retrospectively analyzed 54 samples of ARDS patients from a sepsis registry that was prospectively collected from March 2011 to February 2018, along with 30 non-ARDS controls. The cohort was divided into direct and indirect ARDS. Metabolite concentrations of five analyte classes (energy metabolism, free fatty acids, amino acids, phospholipids, sphingolipids) were measured using liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry by targeted metabolomics.
RESULTS: In total, 186 metabolites were detected. Among them, 102 metabolites could differentiate sepsis-induced ARDS patients from the non-ARDS controls, while 14 metabolites could discriminate sepsis-induced ARDS subphenotypes. Using partial least-squares discriminant analysis, we showed that sepsis-induced ARDS patients were metabolically distinct from the non-ARDS controls. The main distinguishing metabolites were lysophosphatidylethanolamine (lysoPE) plasmalogen, PE plasmalogens, and phosphatidylcholines (PCs). Sepsis-induced direct and indirect ARDS were also metabolically distinct subgroups, with differences in lysoPCs. Glycerophospholipid and sphingolipid metabolism were the most significant metabolic pathways involved in sepsis-induced ARDS biology and in sepsis-induced direct/indirect ARDS, respectively.
CONCLUSION: Our study demonstrated a marked difference in metabolic patterns between sepsis-induced ARDS patients and non-ARDS controls, and between sepsis-induced direct and indirect ARDS subpheonotypes. The identified metabolites and pathways can provide clues relevant to the diagnosis and treatment of individuals with ARDS.
参考来源
- Chang Y, Yoo HJ, Kim SJ, et al. A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes. Crit Care. 2023. PMID: 37408042. doi:10.1186/s13054-023-04552-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。